| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $37.2M | -10.8% |
| SG&A Expense | $10.6M | -13.7% |
| Operating Income | -$47.8M | +11.4% |
| Income Tax | $0 | — |
| Net Income | -$23.5M | +30.9% |
| EPS (Basic) | -$0.32 | +62.8% |
| EPS (Diluted) | -$0.32 | +62.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.8M | +47.2% |
| Current Assets | $48.0M | +62.4% |
| Total Assets | $48.4M | +60.1% |
| Current Liabilities | $13.9M | +25.0% |
| Total Liabilities | $14.1M | +22.9% |
| Stockholders' Equity | $34.3M | +82.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.6M | +13.6% |
| Capital Expenditures | $4K | +0.0% |
| Investing Cash Flow | $9K | +325.0% |
| Financing Cash Flow | $36.6M | +55.2% |
| Free Cash Flow | -$24.6M | +13.6% |